Klaria Pharma Holding AB (6FN) Stock Statistics & Valuation Metrics

Klaria Pharma Holding AB has a market cap or net worth of €11.87M. The enterprise value is ―.

Klaria Pharma Holding AB has 144,758,770 shares outstanding. The number of shares has decreased by -2.65% in one year.

Klaria Pharma Holding AB’s return on equity (ROE) is -14.44 and return on invested capital (ROIC) is -795.59%.

The current PE Ratio of Klaria Pharma Holding AB is -0.87. Klaria Pharma Holding AB’s PEG ratio is 0.60.

In the last 12 months, Klaria Pharma Holding AB had revenue of 2.25M and earned -47.75M in profits. Earnings per share was -0.38.

In the last 12 months, operating cash flow was -12.52M and capital expenditures 0.00, giving a free cash flow of -12.52M billion.

Klaria Pharma Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―

Klaria Pharma Holding AB upcoming earnings date is May 21, 2025, TBA Not Confirmed.

Klaria Pharma Holding AB as a current ratio of 0.05, with Debt / Equity ratio of 0.00%

In the past 12 months, Klaria Pharma Holding AB has paid 18.00K in taxes.

Klaria Pharma Holding AB EV to EBITDA ratio is -2.06, with an EV/FCF ratio of -3.45.

Klaria Pharma Holding AB has €598.00K in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€598.00K billion.

Gross margin is 99.63%, with operating margin of -1388.21%, and net profit margin of -2124.11%.

The average price target for Klaria Pharma Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―